| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.697 | 24.049 | 23.642 | 23.208 | 22.759 | 22.327 | 21.832 | 21.900 | 21.834 | 21.712 |
| Total Income - EUR | 20.697 | 24.049 | 23.642 | 23.208 | 22.759 | 22.327 | 21.832 | 21.900 | 21.834 | 21.712 |
| Total Expenses - EUR | 11.868 | 12.586 | 13.087 | 10.779 | 16.081 | 12.753 | 10.450 | 7.117 | 20.693 | 31.953 |
| Gross Profit/Loss - EUR | 8.830 | 11.463 | 10.555 | 12.430 | 6.678 | 9.574 | 11.383 | 14.783 | 1.140 | -10.242 |
| Net Profit/Loss - EUR | 8.209 | 10.982 | 10.319 | 12.197 | 6.450 | 9.351 | 11.164 | 14.126 | 948 | -10.893 |
| Employees | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medicatus Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.568 | 1.071 | 580 | 106 | 0 | 0 | 0 | 0 | 463 | 21.448 |
| Current Assets | 23.260 | 10.818 | 10.597 | 12.868 | 7.349 | 12.531 | 19.626 | 18.365 | 11.509 | 5.138 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 117 | 0 | 0 | 0 | 0 | 0 | 4.043 | 3.116 |
| Cash | 23.260 | 10.818 | 10.480 | 12.868 | 7.349 | 12.531 | 19.626 | 18.365 | 7.465 | 2.022 |
| Shareholders Funds | 23.926 | 11.033 | 10.369 | 12.247 | 6.499 | 11.591 | 19.264 | 17.634 | 10.846 | -108 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 903 | 856 | 808 | 727 | 851 | 940 | 361 | 732 | 1.125 | 26.730 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medicatus Srl